Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

MM16: Update on Durability of Adaptive Immune Responses to SARS-CoV-2

In this presentation, Professor Sharon Lewin discusses the recent data on the durability of antibody and T cell responses to SARS-CoV-2 and the implications for reinfection.
Sharon R. Lewin, AO, FRACP, FAHMS
Released: September 4, 2020

Information on this Educational Activity

Faculty

Sharon R. Lewin, AO, FRACP, FAHMS

Director, The Peter Doherty Institute for Infection and Immunity
Professor of Infectious Diseases
Faculty Medicine Dentistry and Health Sciences
University of Melbourne and Royal Melbourne Hospital
Consultant Infectious Diseases Physician
Department of Infectious Diseases
Royal Melbourne Hospital and Alfred Hospital
Melbourne, Australia

Sharon Lewin, AO, FRACP, PhD, FAAHMS, has disclosed that she has received consulting fees from AbbVie, Gilead Sciences, and ViiV Healthcare; funds for research support from Leidos; and other financial or material support from Gilead Sciences, Merck, and ViiV Healthcare.

Program Medium

This program has been made available online.

Related Content

Download free slides reviewing the latest updates on COVID-19 epidemiology and emerging data on diagnosis, symptoms, management, and treatment

Ada Adimora, MD, MPH Sharon R. Lewin, AO, FRACP, FAHMS Jens D. Lundgren, MD, DMSc Vikramjit Mukherjee, MD Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS Released: October 26, 2020

Professor Leo Yee-Sin discusses data on the incidence of community- and hospital-acquired secondary infections in patients with COVID-19, from CCO

Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS Released: October 22, 2020

Dr. Jens Lundgren discusses recently published and unpublished data on the use of immunomodulatory agents to treat COVID-19 from CCO

Jens D. Lundgren, MD, DMSc Released: October 16, 2020

This presentation by Dr. Vikram Mukherjee discusses key expert recommendations for the management of comorbid conditions in patients with COVID-19.

Vikramjit Mukherjee, MD Released: October 9, 2020
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Educational grant provided by
Gilead Sciences, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue